Alcohol Use Disorder

GLP-1 Drug Semaglutide Substantially Reduced Heavy Alcohol Consumption and Weight in Patients with Alcohol Use Disorder and Obesity
Researchers have reported positive results in the first clinical trial testing the diabetes and weight-loss medicine semaglutide (Ozempic, Wegovy) in treatment-seeking patents with alcohol use… Read More
GLP-1 Drug Semaglutide (Ozempic, Wegovy) Reduced Heavy Drinking & Craving in Adults with Alcohol Use Disorder
A preliminary, phase 2 clinical trial has shown the potential benefit of a class of popular medications so far approved for control of diabetes and obesity to help reduce alcohol consumption and… Read More
Alcohol-Regulating Hormone Delivered in Combination With GLP-1 Drug Could Have Potential Application in Alcohol Use Disorder, Animal Study Suggests
Researchers led by a BBRF grantee report new research extending knowledge about how a naturally occurring hormone called FGF21 helps to regulate alcohol consumption. Using a synthetic analogue of the… Read More
Alcohol Use Worsens Bipolar Symptoms, Study Finds
Bipolar disorder (BD) is characterized by extreme mood swings. About half of people with BD also struggle with alcohol use problems. Both conditions are harmful on their own, but when they happen… Read More
Unique Neural Activation Pattern in People With Co-Occurring Bipolar Disorder and Alcohol Use Disorder Points to Future Treatment Targets
Nearly 40% of people diagnosed with bipolar disorder (BD) are considered likely to be affected by alcohol-use disorder (AUD) over their lifetime. Read More